Cite
APA Citation
Massari, F., Modena, A., Ciccarese, C., Pilotto, S., Maines, F., Bracarda, S., Sperduti, I., Giannarelli, D., Carlini, P., Santini, D., Tortora, G., Porta, C., & Bria, E. (2016). addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.. Critical reviews in oncology/hematology, 98, 254–263. http://access.bl.uk/ark:/81055/vdc_100030956662.0x00000d